EXPORT CITATION

Chapter-07 Myocardial Infarction

BOOK TITLE: Practical Cardiology

Author
1. Khan M Gabriel
ISBN
9789386056016
DOI
10.5005/jp/books/18060_8
Edition
1/e
Publishing Year
2018
Pages
37
Author Affiliations
1. University of Ottawa; The Ottawa Hospital, Ottawa, Ontario, Canada
Chapter keywords
Myocardial infarction, MI, acute MI, atheroma, atherothrombosis, postinfarction randomized control trial, treatment therapy, intracranial hemorrhage, fatal myocardial infarction

Abstract

It is estimated that in the year 2025 more than 25 million people will die of cardiovascular disease (CVD) and approximately 11 million from acute myocardial infarction (MI) in a world population of approximately 7.9 billion. Approximately, 50% of these fatal MI deaths (>5 million) are sudden, within 1 hour. These deaths are caused by atheroma and subsequent thrombosis (atherothrombosis). Atheroma is the cause of fatal and nonfatal MI. Research must be directed at prevention of atheroma formation and progression. The thrombotic phase is late and researchers and interventional cardiologists are mainly engaged in strategies to define vulnerable atheroma plaques. Many investigative tools and testing are being developed to identify vulnerable plaques, and placement of stents can be done for a few wealthy individuals; a spit in the ocean, expecting the tide to rise. This chapter covers the postinfarction randomized control trials, triggers for atheroma and acute MI, diagnosis, treatment therapy, intracranial hemorrhage, Non-ST-segment elevation MI, and new concepts for prevention of fatal MI or sudden death.

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved

Powered by MPS ScholarStor